Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
A Response to the Letter to the Editor: "Durable Benefit Beyond Response: Reinterpreting Amivantamab Efficacy in METex14 NSCLC Subgroups".
Matthew G Krebs, Byoung Chul Cho, Priya Kim, Alexander I Spira, Natasha B Leighl
Published: 202510.1016/j.jtho.2025.07.003
No abstract available for this study.